Further, our results on higher plasma concentrations of AGEs in T2DM patients, carriers of either the GSTM1 null or GSTT1 null genotype, suggest that deficient activity of these enzymes would make individuals more susceptible to the oxidative stress-related complications of disease. The gene discussed is GSTM1; the disease is type 2 diabetes mellitus.